 | • レポートコード：MRC2-11QY04967 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器・消耗品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はブドウ膜炎治療のグローバル市場について調査・分析したレポートです。種類別（前部ブドウ膜炎、後部ブドウ膜炎、中等度ブドウ膜炎、乳頭炎）市場規模、用途別（病院薬局、小売薬局、オンライン薬局、ドラッグストア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ブドウ膜炎治療の競争状況、市場シェア ・世界のブドウ膜炎治療市場：種類別市場規模 2015年-2020年（前部ブドウ膜炎、後部ブドウ膜炎、中等度ブドウ膜炎、乳頭炎） ・世界のブドウ膜炎治療市場：種類別市場規模予測 2021年-2026年（前部ブドウ膜炎、後部ブドウ膜炎、中等度ブドウ膜炎、乳頭炎） ・世界のブドウ膜炎治療市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局、ドラッグストア） ・世界のブドウ膜炎治療市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局、ドラッグストア） ・北米のブドウ膜炎治療市場分析：米国、カナダ ・ヨーロッパのブドウ膜炎治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのブドウ膜炎治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のブドウ膜炎治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのブドウ膜炎治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Allergan、Bausch & Lomb、Novartis、AbbVie、Santen Pharmaceutical、Eyegate Pharmaceuticals、Alimera Sciences ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Uveitis is considered to be the leading cause for blindness in the U.S. with a gradual rise in prevalence.
North America and APAC regions expected to be major contributors in the expansion of the global uveitis treatment market.
Market Analysis and Insights: Global Uveitis Treatment Market
The global Uveitis Treatment market size is projected to reach US$ 414.9 million by 2026, from US$ 395.1 million in 2020, at a CAGR of 4.6%% during 2021-2026.
Global Uveitis Treatment Scope and Market Size
Uveitis Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Uveitis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Allergan
Bausch & Lomb
Novartis
AbbVie
Santen Pharmaceutical
Eyegate Pharmaceuticals
Alimera Sciences
…
Market segment by Type, the product can be split into
Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Panuveitis
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Uveitis Treatment Revenue
1.4 Market by Type
1.4.1 Global Uveitis Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Anterior Uveitis
1.4.3 Posterior Uveitis
1.4.4 Intermediate Uveitis
1.4.5 Panuveitis
1.5 Market by Application
1.5.1 Global Uveitis Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.5.5 Drug Stores
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Uveitis Treatment Market Perspective (2015-2026)
2.2 Global Uveitis Treatment Growth Trends by Regions
2.2.1 Uveitis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Uveitis Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Uveitis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Uveitis Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Uveitis Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Uveitis Treatment Players by Market Size
3.1.1 Global Top Uveitis Treatment Players by Revenue (2015-2020)
3.1.2 Global Uveitis Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Uveitis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Uveitis Treatment Market Concentration Ratio
3.2.1 Global Uveitis Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Uveitis Treatment Revenue in 2019
3.3 Uveitis Treatment Key Players Head office and Area Served
3.4 Key Players Uveitis Treatment Product Solution and Service
3.5 Date of Enter into Uveitis Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Uveitis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Uveitis Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Uveitis Treatment Market Size by Application (2015-2020)
5.2 Global Uveitis Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Uveitis Treatment Market Size (2015-2020)
6.2 Uveitis Treatment Key Players in North America (2019-2020)
6.3 North America Uveitis Treatment Market Size by Type (2015-2020)
6.4 North America Uveitis Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Uveitis Treatment Market Size (2015-2020)
7.2 Uveitis Treatment Key Players in Europe (2019-2020)
7.3 Europe Uveitis Treatment Market Size by Type (2015-2020)
7.4 Europe Uveitis Treatment Market Size by Application (2015-2020)
8 China
8.1 China Uveitis Treatment Market Size (2015-2020)
8.2 Uveitis Treatment Key Players in China (2019-2020)
8.3 China Uveitis Treatment Market Size by Type (2015-2020)
8.4 China Uveitis Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Uveitis Treatment Market Size (2015-2020)
9.2 Uveitis Treatment Key Players in Japan (2019-2020)
9.3 Japan Uveitis Treatment Market Size by Type (2015-2020)
9.4 Japan Uveitis Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Uveitis Treatment Market Size (2015-2020)
10.2 Uveitis Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Uveitis Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Uveitis Treatment Market Size by Application (2015-2020)
11 India
11.1 India Uveitis Treatment Market Size (2015-2020)
11.2 Uveitis Treatment Key Players in India (2019-2020)
11.3 India Uveitis Treatment Market Size by Type (2015-2020)
11.4 India Uveitis Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Uveitis Treatment Market Size (2015-2020)
12.2 Uveitis Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Uveitis Treatment Market Size by Type (2015-2020)
12.4 Central & South America Uveitis Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Allergan
13.1.1 Allergan Company Details
13.1.2 Allergan Business Overview
13.1.3 Allergan Uveitis Treatment Introduction
13.1.4 Allergan Revenue in Uveitis Treatment Business (2015-2020))
13.1.5 Allergan Recent Development
13.2 Bausch & Lomb
13.2.1 Bausch & Lomb Company Details
13.2.2 Bausch & Lomb Business Overview
13.2.3 Bausch & Lomb Uveitis Treatment Introduction
13.2.4 Bausch & Lomb Revenue in Uveitis Treatment Business (2015-2020)
13.2.5 Bausch & Lomb Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Uveitis Treatment Introduction
13.3.4 Novartis Revenue in Uveitis Treatment Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 AbbVie
13.4.1 AbbVie Company Details
13.4.2 AbbVie Business Overview
13.4.3 AbbVie Uveitis Treatment Introduction
13.4.4 AbbVie Revenue in Uveitis Treatment Business (2015-2020)
13.4.5 AbbVie Recent Development
13.5 Santen Pharmaceutical
13.5.1 Santen Pharmaceutical Company Details
13.5.2 Santen Pharmaceutical Business Overview
13.5.3 Santen Pharmaceutical Uveitis Treatment Introduction
13.5.4 Santen Pharmaceutical Revenue in Uveitis Treatment Business (2015-2020)
13.5.5 Santen Pharmaceutical Recent Development
13.6 Eyegate Pharmaceuticals
13.6.1 Eyegate Pharmaceuticals Company Details
13.6.2 Eyegate Pharmaceuticals Business Overview
13.6.3 Eyegate Pharmaceuticals Uveitis Treatment Introduction
13.6.4 Eyegate Pharmaceuticals Revenue in Uveitis Treatment Business (2015-2020)
13.6.5 Eyegate Pharmaceuticals Recent Development
13.7 Alimera Sciences
13.7.1 Alimera Sciences Company Details
13.7.2 Alimera Sciences Business Overview
13.7.3 Alimera Sciences Uveitis Treatment Introduction
13.7.4 Alimera Sciences Revenue in Uveitis Treatment Business (2015-2020)
13.7.5 Alimera Sciences Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Uveitis Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Uveitis Treatment Revenue
Table 3. Ranking of Global Top Uveitis Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Uveitis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Anterior Uveitis
Table 6. Key Players of Posterior Uveitis
Table 7. Key Players of Intermediate Uveitis
Table 8. Key Players of Panuveitis
Table 9. Global Uveitis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Uveitis Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Uveitis Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Uveitis Treatment Market Share by Regions (2015-2020)
Table 13. Global Uveitis Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Uveitis Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Uveitis Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key Uveitis Treatment Players
Table 20. Global Uveitis Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global Uveitis Treatment Market Share by Players (2015-2020)
Table 22. Global Top Uveitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Uveitis Treatment as of 2019)
Table 23. Global Uveitis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Uveitis Treatment Product Solution and Service
Table 26. Date of Enter into Uveitis Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Uveitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global Uveitis Treatment Market Size Share by Type (2015-2020)
Table 30. Global Uveitis Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global Uveitis Treatment Market Size Share by Application (2015-2020)
Table 32. Global Uveitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global Uveitis Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players Uveitis Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Uveitis Treatment Market Share (2019-2020)
Table 36. North America Uveitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America Uveitis Treatment Market Share by Type (2015-2020)
Table 38. North America Uveitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America Uveitis Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players Uveitis Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Uveitis Treatment Market Share (2019-2020)
Table 42. Europe Uveitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Uveitis Treatment Market Share by Type (2015-2020)
Table 44. Europe Uveitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Uveitis Treatment Market Share by Application (2015-2020)
Table 46. China Key Players Uveitis Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players Uveitis Treatment Market Share (2019-2020)
Table 48. China Uveitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China Uveitis Treatment Market Share by Type (2015-2020)
Table 50. China Uveitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China Uveitis Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players Uveitis Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Uveitis Treatment Market Share (2019-2020)
Table 54. Japan Uveitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Uveitis Treatment Market Share by Type (2015-2020)
Table 56. Japan Uveitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Uveitis Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Uveitis Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Uveitis Treatment Market Share (2019-2020)
Table 60. Southeast Asia Uveitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Uveitis Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia Uveitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Uveitis Treatment Market Share by Application (2015-2020)
Table 64. India Key Players Uveitis Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players Uveitis Treatment Market Share (2019-2020)
Table 66. India Uveitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India Uveitis Treatment Market Share by Type (2015-2020)
Table 68. India Uveitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India Uveitis Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Uveitis Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Uveitis Treatment Market Share (2019-2020)
Table 72. Central & South America Uveitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Uveitis Treatment Market Share by Type (2015-2020)
Table 74. Central & South America Uveitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Uveitis Treatment Market Share by Application (2015-2020)
Table 76. Allergan Company Details
Table 77. Allergan Business Overview
Table 78. Allergan Product
Table 79. Allergan Revenue in Uveitis Treatment Business (2015-2020) (Million US$)
Table 80. Allergan Recent Development
Table 81. Bausch & Lomb Company Details
Table 82. Bausch & Lomb Business Overview
Table 83. Bausch & Lomb Product
Table 84. Bausch & Lomb Revenue in Uveitis Treatment Business (2015-2020) (Million US$)
Table 85. Bausch & Lomb Recent Development
Table 86. Novartis Company Details
Table 87. Novartis Business Overview
Table 88. Novartis Product
Table 89. Novartis Revenue in Uveitis Treatment Business (2015-2020) (Million US$)
Table 90. Novartis Recent Development
Table 91. AbbVie Company Details
Table 92. AbbVie Business Overview
Table 93. AbbVie Product
Table 94. AbbVie Revenue in Uveitis Treatment Business (2015-2020) (Million US$)
Table 95. AbbVie Recent Development
Table 96. Santen Pharmaceutical Company Details
Table 97. Santen Pharmaceutical Business Overview
Table 98. Santen Pharmaceutical Product
Table 99. Santen Pharmaceutical Revenue in Uveitis Treatment Business (2015-2020) (Million US$)
Table 100. Santen Pharmaceutical Recent Development
Table 101. Eyegate Pharmaceuticals Company Details
Table 102. Eyegate Pharmaceuticals Business Overview
Table 103. Eyegate Pharmaceuticals Product
Table 104. Eyegate Pharmaceuticals Revenue in Uveitis Treatment Business (2015-2020) (Million US$)
Table 105. Eyegate Pharmaceuticals Recent Development
Table 106. Alimera Sciences Company Details
Table 107. Alimera Sciences Business Overview
Table 108. Alimera Sciences Product
Table 109. Alimera Sciences Revenue in Uveitis Treatment Business (2015-2020) (Million US$)
Table 110. Alimera Sciences Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Uveitis Treatment Market Share by Type: 2020 VS 2026
Figure 2. Anterior Uveitis Features
Figure 3. Posterior Uveitis Features
Figure 4. Intermediate Uveitis Features
Figure 5. Panuveitis Features
Figure 6. Global Uveitis Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Drug Stores Case Studies
Figure 11. Uveitis Treatment Report Years Considered
Figure 12. Global Uveitis Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Uveitis Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Uveitis Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Uveitis Treatment Market Share by Players in 2019
Figure 17. Global Top Uveitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Uveitis Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Uveitis Treatment Revenue in 2019
Figure 19. North America Uveitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Uveitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Uveitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Uveitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Uveitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Uveitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Uveitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
前部ブドウ膜炎の世界市場（～2026年） Anterior uveitis is an inflammation of the middle layer of the eye. This layer includes the iris (colored part of the eye) and the adjacent tissue, known as the ciliary body. Geographically, the global anterior uveitis market is studied under five main regions namely North America, Latin America, As…- クッシング病治療の世界市場（～2026年） Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…
- 萎縮性胃炎治療の世界市場（～2026年） Atopic gastritis is chronic inflammation of gastric mucosa, and it is a histopathological condition associated with gastric glandular cell and replacement by fibrous tissue, intestinal type epithelium, and pyloric type glands. It mainly associated H. Pylori bacterial infection, and autoimmunity dire…
- 尿路感染症治療の世界市場（～2026年） Urinary tract infection (UTI) is a common infections of the urinary tract, which consists of the kidneys, ureters, bladder, urethra or prostate gland. This trend of increment in the prevalence rate of diabetes among adults is expected to continue during the forecast period. Therefore, with increasin…
- 結節性痒疹治療の世界市場（～2026年） Prurigo nodularis (PN), also known as nodular prurigo, is a skin disease characterised by pruritic (itchy) nodules which usually appear on the arms or legs. Among products, antihistamines are foreseen to exhibit a higher CAGR in the global prurigo nodularis treatment market. Market Analysis and Insi…